Status:
COMPLETED
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
Lead Sponsor:
The Third People's Hospital of Hangzhou
Conditions:
Dermatomyositis
Myocardial Repolarization
Eligibility:
All Genders
20-80 years
Brief Summary
The goal of this observational study is to investigate ventricular repolarization utilizing Tp-e intervals and Tp-e/QT ratios in patients with DM. The main questions it aims to answer are: * 1.Explor...
Eligibility Criteria
Inclusion
- Regardless of gender, registered residence and education level, voluntarily participate in this study and sign the informed consent form.
- Clinical diagnosis of Dermatomyositis.
Exclusion
- Previous history of heart disease (such as myocardial infarction, cardiac pacing, congenital heart disease, ischemic heart disease, etc.), chronic kidney disease, etc; Patients with other connective tissue diseases; Pregnant and lactating women.
- Taking drugs that affect electrocardiogram indicators, such as macrolides, quinolones, quinidine, amiodarone, antipsychotic drugs, etc.
- Patients with severe lack of case data.
Key Trial Info
Start Date :
November 24 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 24 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06002750
Start Date
November 24 2021
End Date
November 24 2022
Last Update
February 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Third People's Hospital of Hangzhou
Zhejiang, Hangzhou, China, 310000